Mehrdad Abedi

KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study

Bijal Shah, Armin Ghobadi, Olalekan O. Oluwole et al. · The Lancet · 2021 · 769 citations · Full text

Medicine, Hematology, Oncology +9

Participation of bone marrow derived cells in cutaneous wound healing

Evangelos V. Badiavas, Mehrdad Abedi, Janet Butmarc et al. · Journal of Cellular Physiology · 2003 · 423 citations

Life Sciences, Biomedical Sciences, Cell Biology +12

Non-viral precision T cell receptor replacement for personalized cell therapy

Susan P. Foy, Kyle Jacoby, Daniela A. Bota et al. · Nature · 2022 · 278 citations · Full text

Medicine, Immunology, Oncology +17

Phase I Trial of Anti‐PSMA Designer CAR‐T Cells in Prostate Cancer: Possible Role for Interacting Interleukin 2‐T Cell Pharmacodynamics as a Determinant of Clinical Response

Richard P. Junghans, Qiangzhong Ma, Ritesh Rathore et al. · The Prostate · 2016 · 265 citations

Medicine, Immunology, Oncology +17

KTE-X19 anti-CD19 CAR T-cell therapy in adult relapsed/refractory acute lymphoblastic leukemia: ZUMA-3 phase 1 results

Bijal Shah, Michael R. Bishop, Olalekan O. Oluwole et al. · Blood · 2021 · 200 citations · Full text

Medicine, Hematology, Oncology +16